Versantis receives FDA rare paediatric disease designation for VS-01 to treat urea cycle disorders

This article was originally published here

UCD is a rare and life-threatening condition caused by an inherited inborn error of metabolism. Current treatment options are associated with poor outcomes. “The rare pediatric disease designation

The post Versantis receives FDA rare paediatric disease designation for VS-01 to treat urea cycle disorders appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply